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The  specificity of antibody and  its adaptation  to  a  deternlinant  (1)  is  de- 
pendent on and reflected by the specificity of cell receptors (2-5) on bone mar- 
row-derived cells (6). Antibody synthesis is triggered by the interaction between 
cell  receptor  and  antigenic  determinant.  This  type  of interaction  is  not  the 
only requirement for the induction  of antibody synthesis;  the involvement of 
other determinants (i.e. those of the carrier) is as crucial as is that of the first 
mentioned determinant (7-11). However, the role of these carrier determinants 
is not reflected by the specificity of the antibody itself. Thus the immune re- 
sponse appears not only to be regulated by the specificity of the determinant 
against which  antibody is made, but also by the specificity of other  determi- 
nants. In addition, the antibody response may be regulated by other processes 
which are unrelated to the specificity of the ultimately synthesized antibody. 
The  latter  components  of regulation,  though  dependent  on  the  initial  inter- 
action with a particular determinant, may have a generalized effect on respon- 
siveness and may affect the  extent of the  response to many structurally  un- 
related antigens. Processes of this type may be implicated in such phenomena 
as  the  synthesis  of  nonspecific  immunoglobulins  after  antigenic  stimulation 
(12-15),  and  also  in  some  of  the  phenomena  which  have  been  classified  as 
"adjuvanticity"  (16). We shall refer to processes of regulation, which may de- 
pend on an initial  event of recognition but may affect the  response to struc- 
turally unrelated antigens, as nonspecific regulatory processes. We shall report, 
here, a phenomenon which may be mediated by such a  nonspecific regulatory 
process.  This  phenomenon,  antigenic  promotion,  occurs  between  antigens 
which have no known common or cross-reacting determinants. This effect is ob- 
served in  the hapten  antibody response to  such  antigens  as para-azobenzene 
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arsonic  acid  derivatives  of human  albumin  and  of  dissociated  keyhole  limpet 
hemocyanin  and  is  detected  by  plaque  formation  with  diazotized  red  cells  as 
targets  (17-19). 
Materials  and Methods 
Para-Arsanilic Acid.--p-Arsanilic acid was obtained from Aldrich Chemical Co., Inc., Mil- 
waukee, Wis. 
Aluminum Potassium Sulfate.--Aluminium  potassium sulfate,  AnalaR, was obtained from 
the British Drug Houses, Ltd., Poole, Dorset, England. 
Agarose.--Agarose  was obtained from L'Industrie Biologique Francaise S.A., Gennevilliers, 
France. 
CMRL 1066 Medium.--CMRL  1066 medium, prepared by the method of Parker (20), was 
obtained from the Ontario Cancer Institute, Toronto, Canada. 
Horse and Sheep  Erythrocytes.--Horse  erythrocytes (HRBC) a and sheep erythrocytes were 
prepared from blood obtained from Woodlyn Laboratories Ltd., Guelph, Ontario, Canada. 
Human Serum Albumln.--Human  serum albumin "reinst" (HA) was obtained from Beh- 
ringwerke A.G.,  Marburg-Lahn,  West  Germany. 
Rabbit Serum Albumln.--Rabbit serum albumin (RA) was obtained from Pentex Biochemi- 
cals,  Kankakee, Ill. 
Human Gamma Globulin.--Human gamma globulin (HGG) was purified by passing human 
immune serum globulin, Cohn fraction II,  (Connaught  Medical Research Laboratories, To- 
ronto, Lot No.  36529) through a  diethylaminoethyl  (DEAE)-Sephadex AS0 column equili- 
brated with 0.005 ~  phosphate buffer,  pH 8.0. The first peak was collected and concentrated 
by pressure dialysis through a  Diaflo membrane  (UM-10)  (Amicon Corporation, Lexington, 
Mass.). It gave a single line on immunoelectrophoresis with goat anti-human serum and goat 
anti-human gamma globulin. 
Monomeric  Human Gamma Globulin for Tolerance Inductlon.--HGG was centrifuged for 3 
hr at 20°C and at 105,000 g. The top third of the supernatant was separated and, immediately 
thereafter, samples were injected into newborn rabbits. 
Iodinated  HGG.--HGG was iodinated with 12~I by a modification of the method of Onoue 
et al.  (21). The concentration of HGG employed was 10 rag/1.15 ml so as to obtain a lower 
specific activity. 
Horse Spleen  Ferritin.--Horse spleen ferritin (HSF), Lot No. 900534, six times crystallized, 
cadmium-free, was obtained from Calbiochem, Los Angeles, Calif. 
Lyso~yme.--Lysozyme  (Lys)  of Micrococcus  lysodeikticus,  Lot No.  6904P,  was  obtained 
from Schwarz BioResearch, Orangeburg,  N.Y. 
Tobacco Mosaic Virus.--Tobacco mosaic virus (TMV) was kindly given by Dr. A. Kleckow- 
ski, Rothamstead Experimental Station, Harpenden,  U.K. 
Keyhold  Limpet Hemocyanin.--Some  lots of keyhole limpet hemocyanin  (KLH) were the 
gift of Dr. W. O. Weigle; other lots were prepared by us from giant keyhole limpets obtained 
i Abbreviations  used in this paper:  As, p-azobenzene arsonic acid; B  cell, bone  marrow-de- 
rived cell; HA, human  serum albumin;  HA-As, As-conjugated HA; HGG,  human  gamma 
globulin; HGG-As, As-conjugated HGG; HRBC, horse erythroeytes; HSF, horse spleen fer- 
ritin;  KLH, keyhole limpet hemocyanin; KLH-As, As-conjugated KLH; Lys,  lysozyme of 
Micrococcus  lysodeikticus;  PFC-As, plaque-forming cells detected with SRBC-As (after cor- 
rection for background);  RA, rabbit serum albumin;  RA-As, As-conjugated RA; RBC, red 
blood ceils;  SRBC, sheep erythrocytes; SRBC-As, As-conjugated SRBC; T  ceil,  thymus-de- 
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from Pacific Biomarine Supply Co., Venice, Calif. The crude material was purified by the 
method  of  Campbell et  ai.  (22). 
Dissociated Keyhole  Limpet ttemocyanin.--Dissociated  keyhole  limpet  hemocyanin was 
prepared from KLH, as described by Weigle (23). 
p-Azobenzene Arsonic Acid Proteins.--p-Azobenzene arsoulc acid  (As) proteins were pre- 
pared by the method of Cinader and Dubert (24). Para-azobenzene arsonic acid human serum 
albumin (HA-As), p-azobenzene arsonic acid human gamma globulin (HGG-As), and p-azo- 
benzene arsonic acid keyhole limpet hemocyanin (KLH-As)  contained, respectively, 7.5,  29, 
and 720 atoms of arsenic per molecule of protein. 
Dissociated KLlt-As.--Dissociated KLH-As was prepared from associated KLH-As by the 
method of Weigle (23). 
Alum Precipitation  of Proteins  and Azo  Proteins.--Protein or azo protein,  10 mg/ml in 
0.15 ~  phosphate-buffered saline (pH 7.2), was added to an equal volume of 10% w/v aiu- 
minium potassium sulfate; 0.1 N NaOH was added dropwise while the  solution was  stirred. 
Addition was completed when the pH stabilized at 7.0. The precipitates were washed twice and 
resuspended in 0.15 ~  phosphate-buffered saline. 
Immunization.--New Zealand white rabbits (Rieman Fur Ranches Ltd.,  St. Agatha, On- 
tario,  Canada; 2-3 kg in body weight unless otherwise specified) were used.  Antigens were 
dissolved or suspended at a  concentration such that the injected volume was  always 0.5 ml. 
Injections were given subcutaneously into one or both hind footpads. 
Induction  of Immunological Tolerance to HGG.--Newborn rabbits were injected intraperi- 
toneally with 5 mg of monomeric HGG (in 1 ml of 0.15 ~  NaC1) within 12 hr of birth; two 
similar injections were given 24 and 48 hr later. 
Test for Tolerance to ttGG.--On the 31st day of life, 2.5 mg of alum-precipitated HGG was 
injected into the tight hind footpad of neonatally injected rabbits. 4  days later, 125I-labeled 
HGG was injected intravenously (I mg/kg body weight). Thereafter, rabbits were bled regu- 
larly; radioactivity in the serum was counted in an automatic gamma scintillation counter 
(Model 42245, Nuclear-Chicago  Corp., Des Plaines, Ill.). Rabbits immune to HGG showed 
immune phase of elimination without distinguishable metabolic phase.  Rabbits tolerant to 
HGG showed no immune phase but a prolonged metabolic phase of elimination. 
tIapten-Spedfic  ttemolytic Plaque Assay (PFC-As Assay; references 17 and 18).--Popliteal 
lymph nodes, draining the injection sites, were dissected out. Single cell suspensions were pre- 
pared by cutting the nodes with a pair of scissors into small pieces and squeezing the fragments 
through fine stainless steel gauze (100 X  100 mesh). Cells were washed once in chilled CMRL 
1066 medium and were resuspended in the medium at a  concentration of 3  X  107  nucleated 
cells/ml. Fractions of the lymph node cells were used. Each assay mixture contained 3 X  106 
lymph node cells,  2 X  l0  s p-azobenzene arsonic acid-conjugated sheep erythrocytes (SRBC- 
As)  (19) and 2.0 ml of 0.6% agarose in CMRL 1066 medium. The mixture was incubated at 
37°C for 2 hr. Thereafter, guinea pig serum, as a  complement source, was layered above the 
agarose and incubation was continued for 45 rain. All assays were carried out in triplicate. 
Background plaques were obtained by using SRBC-As as target ceils in the presence of 5.0 
/zmoles of p-arsanilic acid/incubation mixture (19). In some eases, normal sheep erythrocytes 
were used as target cells so as to determine the number of background plaques. There was no 
difference in the number of background plaques obtained by these two methods. 
Enumeration of PFC-As and Nonparametric Statistical Tests.--The number of PFC-As per 
incubation mixture (containing 3  X  106 nucleated cells as described in the preceding section) 
was obtained by subtraction of the background plaques per plate from the total. The number 
of PFC-As per node was obtained by multiplying the number of PFC-As/3 X  106 cells with an 
appropriate factor based on the total number of nucleated cells in the node. When the total 
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considered that there were minimally 0 PFC-As and maximally 2 PFC-As/3  X  106 cells. To 
test for the difference in response between two groups, the Wilcoxon rank sum test (25)  was 
employed. The numbers of PFC-As per node of individual rabbits of one group were compared 
with that of the second group. For those rabbits whose lymph node cells gave not more than 
2  plaques/3  X  106  ceils above the background,  either the minimal values or the maximal 
values of PFC-As per node were assigned to them for the test. It was found that a test using 
the maximal values always gave a lower value of P  than did the corresponding test using the 
minimal values.  The lower P  values are attributable  to larger cell contents of preinjected 
lymph nodes and hence to larger values for the plaque number of preinjected nonresponders. 
The results of the statistical tests, presented in the tables, are based on minimal  values. 
TABLE  I 
H~t~-Sp~ificPlaque Responseto Differentp~zobenzeneArsonicAdd  Protdns 
Group  Antigens injected  No. of  rabbits 
loglo (PFC-As/node)* 
Mean  sD 
a  HA-As  8  0.3  0.9 
b  Dissociated KLH-As  4  0.7  1.3 
c  Associated KLH-As  4  3.2  0.2 
d  HGG-As (in 0.15 x~ NaCI)  4  1.8  2.1 
e  HGG-As (alum-precipitated)  4  4.6  0.7 
One of five azo proteins (0.5 rag) was injected into the right hind footpad of the rabbit. 
The azo proteins were HA-As (in 0.15 M NaC1), dissociated KLH-As (in 0.2 ~  borate buffer, 
pH 8.8), associated KLH-As (in 0.15 ~ NaC1), HGG-As (in 0.15 ~ NaC1), or alum-precipitated 
HGG-As  (in 0.15  M phosphate-buffered saline, pH  7.2).  8  days later,  PFC-As assays were 
carried out with cells of right popliteal lymph nodes of these animals. 
* Comparison of individual values between groups by the Wilcoxon rank sum test: 
a vs. b, P  >  0.05;  a  vs. c, P  <  0.01 
a  vs. d, P  >  0.05;  a vs. e, P  <  0.01 
b vs. c, -P <  0.05;  d vs. e, P  =  0.05 
To  avoid presentation of the individual values, on which our statistical comparisons are 
based, we have summarized our data as the mean, standard deviation, and range of the log10 
(PFC-As/node).  For  this purpose only,  nonresponders were arbitrarily  taken  to  have  one 
PFC-As/node. 
Passive Hemagglutination Test.--Agglutination titers with tanned red cells sensitized with 
HA, HGG, HGG-As, or p-azobenzene arsonic acid rabbit serum albumin (RA-As) were deter- 
mined as described by Boyden (26) and as modified by Cin~ler and Pearce (27). Agglutination 
titers with tanned red cells sensitized with KLH or KLH-As, either in associated form or in 
dissociated form, were determined similarly, except that for sensitization of tanned erythro- 
cytes one-tenth of the original concentration of protein was used. 
RESULTS 
Increase  in  the Number  of Hapten-Specific  Plaque-Forming  Cells after  Pre- 
injection with Unrelated Macromolecules.--The  magnitude  of  the  antibody  re- 
sponse to the hapten, p-azobenzene  arsonic acid, depends on the identity and  on CItlN-YU WU  AND  BERNHARD CINADER  697 
the state of aggregation of the carrier (Table I). Human albumin was the weak- 
est of the carriers we have tested. None of eight rabbits that had received an in- 
jection with 0.5 mg of HA-As into the footpad and whose lymph nodes had been 
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FIG. 1.  The effect of preinjection with KLH  on the response to HA-As-PFC-As assay. 
NaC1 (0.15 ~a) or KLH (2.5 mg in 0.15 M NaC1) was injected into the right hind footpad of 
the rabbit. 4 days later, 0.5 rag, 1.5 mg, or 5.0 mg of HA-As (in 0.15 M NaC1) was injected 
into the same footpad of the rabbit. PFC-As assay with cells of the draining popliteal lymph 
nodes were carried out 4-10 days after the injection with HA-As. This time interval is indi- 
cated on the horizontal axis. The vertical axis represents the logl0 of the number of PFC-As 
per node. Each point represents the geometric mean of the number of PFC-As per node ob- 
tained from five to nine rabbits. 
Panel  1st injection  2nd injection  Symbols for geo- 
metric mean of 
PFC-As/node 
left-hand side 
right-hand side 
NaC1; 0.15 M  HA-As; 0.5 mg  --©-- 
NaC1; 0.15 M  HA-As; 1.5 mg  --/X-- 
NaC1; 0.15 M  HA-As; 5.0 mg  --e-- 
KLH; 2.5 mg  HA-As; 0.5 mg  O 
KLH; 2.5 mg  HA-As; 1.5 mg  --A-- 
KLH; 2.5 mg  HA-As; 5.0 mg  --e-- 
assayed 5  days  later had  demonstrable plaque-forming cells in  the  draining 
lymph node. Even 8 days after the injection, seven out of eight rabbits did not 
have demonstrable plaque-forming cells in the lymph node (Fig. 1). However, 
more plaque-forming cells per 3  X  10  6 lymph node cells and per lymph node 
were detected if the rabbits were injected with one of several unrelated proteins 
4 days before the administration of HA-As. Different proteins differed in their 698  ANTIGENIC  PRO?~IOTION 
capacity to increase the number of plaque-fomring cells in the draining lymph 
nodes of  the  responders  (Table II,  groups a-g).  The increase in the hapten- 
specific plaque response,  as  a  consequence of preinjection with  an unrelated 
TABLE II 
The Effect  of Preinjection  with  Various  Antigens on Hapten-Specific  Plaques  to HA-As or to 
Dissociated KLH-A s 
o 
First injection 
HSF 
KLH 
Lys 
HRBC 
TMV 
Dissociated KLH 
0.15 ~ NaCI 
Alum-precipitated 
HGG 
Alum precipitate 
HGG 
Phosphate-buff- 
ered saline 
Test injection 
IHA-As 
J 
I 
Fraction i  log10 (PFC-As/node) 
of re-  ,I 
sponders*] Mean  so  Range 
8/9  2.6  1.1 
14/22  2.1  1.7 
4/6  2.0  1.6 
3/5  1.7  1.5 
4/9  1.3  1.5 
1/8  0.4  1.1 
0/8  0  0 
18/20  2.9  1.2 
3/9  1.0  1.5 
2/5  0.9  1.2 
2/5  1.0  1.1 
Dissociated 
KLH-As 
0-3.5 
0-4.0 
0-3.8 
0-2.9 
0-3.2 
0-3.1 
0-0 
0-4.7 
0-3.1 
0-2.3 
0-2.8 
Com- 
parison 
with 
group 
p** 
<0.01 
<0.01 
0.05 
0.i 
0.05-0.1 
>0.2 
<0.01 
>0.2 
>0.2 
On day -4, one of the following reagents was injected into the right hind footpad of the 
rabbit: HSF (2.5 nag), KLH (2.5 rag), Lys (2.5 rag), TMV (2.5 rag), HRBC (6 X 109 cells), 
dissociated KLH (2.5 mg), 0.15 M NaC1, 0.15 M phosphate-buffered saline, pH 7.2, alum- 
precipitated HGG (2.5 mg), alum precipitate or HGG (2.5 mg). The first five antigens were 
given in 0.15 M  NaC1; dissociated KLH was given in 0.2 ~ borate buffer, pit 8.8, and the last 
three  reagents were given in 0.15 ~  phosphate-buffered saline, pH 7.2. 
On day 0, HA-As (0.5 mg in 0.15 ~ NaC1) or dissociated KLH-As (0.5 mg in 0.2 ~ borate 
buffer, pH 8.8) was injected into the right hind footpad of each rabbit. On day 5, PFC-As 
assays were carried out with cells from the right popliteal lymph nodes. 
* Responders are those animals whose lymph nodes give more than two plaques/3  X  106 
cells above background. 
Individual  values of each group were compared with those of group g or group k by the 
Wilcoxon rank sum test. Pretreatment with HSF, KLH, Lys, and alum-precipitated  HGG 
led to PFC-As responses which were significantly higher than the response after pretreat- 
ment with salt solution. 
pretein, was net only observed when HA was the carrier for the hapten but also 
when dissociated keyhole limpet hemocyanin was the carrier for the same hap- 
ten (Table II, groups h-k). It will be seen that the state of antigen aggregation 
(dissociated or associated KLH, soluble or alum-precipitated HGG) had a sim- 
ilar effect on carrier function (Table I) and on the promoting effect (Table II). 
Increase  in  the  Circulating  Hapten  Antibodies  and  Protein  Antibodies  after CHIN-YU WU AND  BERNHARD CINADER  699 
Preinjection with Unrelated  Macromolecules.--The effect of preinjection on the 
response to protein determinants of the subsequently injected antigen was in- 
vestigated next in terms of circulating antibody. Though promotion of response 
to protein determinants was not always observed, it became apparent that pro- 
motion was in some cases not limited to the p-azobenzene arsonic acid response. 
In rabbits preinjected with KLH  and challenged with the antigen HA-As, the 
serum hemagglutination titers against the carrier (HA)  and the antigen (HA- 
As) were increased (Fig. 2, upper panel). In rabbits preinjected with alum-pre- 
cipitated HGG and challenged with dissociated KLH-As, there was no increase 
in the serum hemagglutination titers against the carrier (dissociated KLH)  or 
against the entire antigen (dissociated KLH-As). An increase was found in the 
TABLE III 
PFC-As Response to HA-As in Adjuvant with or without  Preinjection with KLH 
Preinjection  Log10 (PFC-As/node) 
No. of  Time (days 
before the  Comparison  Group  rabbits  Material  injection  Mean  SD  Range  with group I 
of HA-As) 
P 
a  16  none  --  4.0  0.8  2.3-4.8  -- 
b  16  KLH  0.5  2.7  1.7  0-4.5  0.01-0.02 
c  12  KLH  4  4.3  1.1  3.0-5.1  >0.2 
HA-As (5 mg) in complete Freund's adjuvant was injected into the fight hind foopad of 
each rabbit of group a, b, and c.  12 hr or 4  days earlier, each rabbit of group b  and c had 
received an injection of KLH (2.5 mg in 0.15 ~ NaC1) into the right hind footpad. 5 days after 
the injection with HA-As, all rabbits were sacrificed and PFC-As assays were carried out 
with cells of the right popliteal lymph nodes. 
* Comparison of individual values between groups by the Wilcoxon rank sum test. 
titer of antibody directed against the hapten conjugated to a  heterologous pro- 
tein (Fig. 2, lower panel). Clearly, promotion could not only be  demonstrated 
with plaque-forming cells from lymph nodes draining the injection site, but also 
with circulating antibodies. 
The Effect on Promotion of the Dose of the Test Antigen and of Adjuvant.--The 
extent of promotion depended on the dose of HA-As which was injected. It was 
most marked when the dose was small (0.5 rag) and was no longer demonstrable 
when the dose was large (5.0 mg) (Fig. 1) or when the hapten-protein conjugate 
was given in complete Freund's adjuvant (Table III). In the latter instance, re- 
duction in plaque numbers was observed if KLH was given 12 hr before the in- 
jection of HA-As (Table III). 
The Effect on Promotion of the Dose of Preinjeeted Antigen.--Promotion de- 
pended on the dose of the promoting antigen. Promotion of response to 0.5 mg 
HA-As was not seen when the dose of the promoting antigen, KLH, was 0.25 700  ANTIGENIC  PROMOTION 
mg or less, but was observed when the dose of KLH was 2.5 mg or more (Table 
IV, groups a-e). When 5 rag instead of 0.5 mg of HA-As was used,  promotion 
was seen only when a large dose of KLH (25 rag) was administered  (Table IV, 
groups f-i). 
Localization of Promotion.--Promotion  depended on the site of the adminis- 
tration of the promoting antigen. Promotion was localized to the lymph node 
which drained the footpad into which the promoting antigen was injected: one 
of several  antigens  was injected  into the right  hind  footpad;  after four days 
HA-As  was injected  into both  the  right  and  the left  hind  footpads.  Hapten- 
o 
I0 
8 
6 
4 
2 
0 
0 
el  • 
i  m  i  . 
4  8  12 
>. 
o 
-o 
...:_ 
c 
=< 
4  8 
Days after injection  with  HA-As 
>. 
o 
>. 
._N 
4  8 
I 
12 
OJ 
C) 
B 
(1) 
>.. 
o 
>. 
lu 
..=- 
c 
<C 
o 
o 
10 
8 
6 
4 
2 
I 
°J" 
e.s / 
lllll 
4  8  12 
o 
c: 
:z: 
o 
o 
./  / 
I  I  I--  I 
4  8 
>. 
o 
"-o 
c 
1-- 
12  0 
Days after  injectian  of dissociated KLH-As 
FIG.  2 
4  8 
I 
12 CIIIN-YU  WU  AND  BERNHARD  CINADER  701 
specific plaques were found only in the right popliteal lymph node, but not in 
the left (Table V). 
Inhibition rather than Promotion of Response after a Second Injection with the 
Promoting Antigen.--If  two rather than one injection of the unrelated antigen 
were  given  before  the  administration  of  the  azo  protein  (HA-As, 0.5 mg), 
promotion was not observed even thcugh the  unrelated protein  and the  azo 
protein were injected into the same footpad. 
It will be seen from Table II that the plaque number was increased over that 
obtained by the injection of HA-As,  given without pretreatment, if HSF or 
KLH was injected 4 days before HA-As. However, there was no promotion if 
HSF or KLH was given twice instead of once, whether the interval between the 
FIo. 2.  The  effect  of  preinjection with  structurally  unrelated  antigens  on  circulating 
antibody.  Animals were preinjected with saline, alum precipitate,  or promoting antigen 4 
days before test injection with a diazotized protein. 5, 8, and 10 days after the test injection, 
the animals were bled. 
No. of  Preinjection  Test injection  Symbol  rabbits 
Upper  9  KLH  (2.5  mg  in  0.15  M~  HA-As  (0.5  mg in 0.15  M  --O-- 
panel  NaC1) 
9  0.15 M NaCI  j  NaC1)  ---O--- 
Lower  6  Alum-precipitated HGG (2.5  /  • 
panel  mg  in  0.15  M phosphate-[ 
dissociated  KLH-As  (0.5 
buffered saline, pH 7.2)  1  mg in 0.2 M borate buffer,  ! 
Alum precipitate  (in 0.15 M  I  pH 8.8) 
phosphate-buffered saline,j 
pH 7.2) 
---O  -- 
The hemagglutination titers of sera were measured with the diazotized immunizing anti- 
gens, with the carrier protein, and with a heterologous diazotized carrier as indicated on the 
vertical axis. A 1/10 dilution of serum was first prepared and thereafter 2-fold dilution steps 
were made. Titers were expressed as log~ of the reciprocal of these 2-fold dilutions. Each point 
represents the mean of the titers of each group on a given day. Titers from animals of paired 
groups were compared by a  two-way analysis of variance: 
Antigens for sensitization of tanned  Comparison between titers 
erythrocytes  of paired groups 
Upper panel 
Lower panel 
(P) 
HA-As  0.01-0.025 
HA  <0.005 
HGG-As  0.05 
Dissociated KLH-As  >0.20 
Dissociated KLH  >0.20 
RA-As  0.001 702  ANTIGENIC  PROMOTION 
two injections with HSF or KLH was 7 or 60 day's (Table VI, groups a-e) nor 
was there promotion when  this interval was fixed at 60 days, and the HA-As 
(0.5 mg) was given 1, 4, 6, or 9 days after the second injection of KLH  (2.5 mg). 
The question arose whether this apparent absence of promotion was, in fact, 
attributable to antigenic competition which obscured the effect of promotion. 
We,  therefore,  designed  experiments  to  test  whether  antigenic  competition 
might be involved. Clearly, antigenic competition could not be demonstrated 
TABLE IV 
PFC-As Response to 0.5 mg or 5.0 mg of HA-As after Preinjection with Various Doses  of KLH 
Fraction of  log10 (PFC-As/node)  Corn- 
Group  Dose of  Dose of  responding  .......  parison  p~. 
KLH  HA As  rabbits*  Mean  SD  Range  with 
group 
(mg)  (mg) 
a  0  ]  0/8  0  0  0-0 
b  0.025  ~  1/5  0.6  1.2  0-2.7 
c  0.25  t  0.5  2/5  1.0  1.3  0-2.6 
d  2.5  I  14,.'22  2.1  1.7  0-4.0 
e  25  j  6/9  2.2  1.6  0--3.7 
f  0  1  7/7  2.8  0.6  2.4-3.9 
g  0.25  /  4/'4  2.6  0.3  2.3-2.8 
h  2.5  !  5.0  4/5  2.5  1.4  0  2.3 
i  25  J  5/5  3.9  0.2  3.6-4.1 
I 
>0.1 
>0.1 
a 
<0.01 
0.02-0.05 
>0.1 
f  >0.i 
0.01-0.02 
Rabbits were divided into nine groups. On day --4, each rabbit of groups a and f received 
an injection of 0.15 ~ NaC1 into the right hind footpad. Each rabbit of groups b-e and g-i 
received an injection with KLH (0.025 mg, 0.25 rag, 2.5 rag, or 25 mg in 0.15 ~ NaC1) into 
the right hind footpad. On day 0, all rabbits received an injection of HA-As (0.5 or 5.0 mg 
in 0.15 M NaC1) into the preinjected footpad. On day 5, all rabbits were sacrificed and PFC- 
As assays were carried out with cells of the right popliteal lymph nodes. 
* Responders  are those animals whose lymph nodes give more than two plaques above 
background/3 X  10  s cells. 
:~ Comparison of individual values between groups by the Wiicoxon rank sum test. 
under  the previously employed experimental conditions in which  the  dose of 
HA-As was so chosen that no plaque response occurred in the absence of pro- 
motion (Table II). Accordingly, we injected larger quantites of HA-As (5 rag) 
which we already knew to induce a  substantial plaque response (Fig. 1). With 
this immunological challenge a  single injection with 2.5  mg of KLH  failed to 
affect the response.  On  the other hand,  a  preceding secondary injection with 
KLH inhibited the plaque response to HA-As (Table VI, groups 5h). It follows 
that antigenic competition might be implicated under the conditions in which 
we had previously failed to demonstrate promotion. 
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far, seen that promotion occurs when the promoting antigen is given for  the 
first time, and that there was a parallel between carrier function and the pro- 
moting effect. On the basis of both these observations, it appeared as though a 
specific interaction between the promoting antigen and a component of the im- 
mune system might be an essential step in the initiation of the promotion which 
we have observed. We now tested this directly. Animals were rendered tolerant 
TABLE V 
Localization of A ntigenic Promotion 
Injection  on day  PFC-As/node* 
--4  0  Right  Left 
Right  Left  Right  Left  popliteal  popliteal 
footpad  footpad  footpad  footpad  node  node 
HSF 
H-RBC 
TMV 
0.15 ~ NaCI  HA-As  HA-As 
<130  <120 
1000  <140 
1500  <110 
<180  <50 
400  <80 
600  <70 
<250  <110 
310  <20 
1200  <130 
On day -4 one of three antigens was injected into the right hind footpad of the rabbit. 
The three antigens were HSF (2.5 mg in 0.15 M  NaC1), TMV (2.5 mg in 0.15 M NaC1), and 
HRBC  (6 X  109 cells in 0.15 M NaC1). On day 0, every rabbit received an injection with 
HA-As (0.5 mg in 0.15 M  NaC1) into each of the two hind footpads. On day 5, PFC-As assays 
were carried out with cells from right and left popliteal lymph nodes. 
* The No. of PFC-As was determined in 3 )< 106 nucleated cells. It was considered to be 
<2/3 )< 106 cells when the total number of plaques/3  X 106 cells did not exceed background 
by more than 2. The number of PFC-As/node was obtained by multiplying the number of 
PFC-As/3 )<  106 cells with an appropriate  factor based on the total number of nucleated 
cells in each node. 
by neonatal injection with HGG (see Materials and Methods); others were left 
uninjected. In later life, both tolerant and normal rabbits were injected with 
alum-precipitated HGG, followed by dissociated KLH-As. It is apparent from 
Table VII that promotion occurred in animals which could respond to HGG but 
not in animals which were unresponsive to this antigen. 
DISCUSSION 
Preinjection with each of several different proteins increased the response to a 
hapten which was conjugated to  a  structurally unrelated protein. This effect 
was seen when the hapten-conjugated protein was given in small quantities, if TABLE  VI 
Different Effects of Primary and Secondary Injections with HSF  or KLH  on the Subsequent 
PFC-As Response to HA-As 
Preinjection  Test  PFC-As 
Group  Time of  injection 
Material  injection  HA-As  per cells3  X 106  per node* 
(day) 
a  HSF  0 
b  HSF  0, 60 
c  KLH  0 
d  KLH  0, 60 
e  KLH  0, 7 
f  0.15 M NaC1  0 
g  KLH  0 
(rag) 
0.5 
5.0 
<2:~  <110 
6  400 
12  1000 
19  1500 
21  1900 
21  3300 
<2  <130 
<2  <130 
<2  -.<170 
<2  <310 
<2  <100 
<2  <150 
3  400 
3  410 
11  840 
9  940 
30  3900 
57  6700 
<2  <50 
..<2  < 140 
<2  <170 
<2  <230 
<2  <270 
<2  ..<310 
<2  <340 
<2  <400 
3  150 
5  240 
6  280 
16  670 
20  740 
21  1100 
123  7300 
<2  <110 
3  680 
12  1200 
9  1400 
10  1600 
8  1900 
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TABLE  VI--Continued 
Group 
Preinjection 
Time of 
Material  injection 
Test 
injection 
HA-As 
PFC-As 
per 3  X  10  ~ 
cells  per node* 
h  KLH 
(day)  (rag) 
0, 7  5.0  <2  <170 
<2  < 180 
<2  < 190 
<2  <200 
<2  <210 
<2  <220 
<2  <300 
4  580 
Rabbits were divided into eight groups. Each rabbit in four of these groups received a 
single injection into the right hind footpad with either HSF (2.5 mg in 0.15 ~t NaCI), KLH 
(2.5 mg in 0.15 •  NaC1), or 0.15 •  NaC1. Rabbits in the remaining four groups were given 
two injections with either HSF or KLH (2.5 mg in 0.15 M  NaC1). 4 days after the primary or 
secondary injections, all rabbits were injected into the right hind footpad with HA-As (0.5 
mg in 0.15 M NaC1 for groups a-e; 5.0 mg in 0.15 ~  NaC1 for groups f-h. 5 days  (groups 
a-e) or 7 days (groups f-h) later, PFC-As assays were carried out with cells from the right 
popliteal lymph nodes. 
* Comparison of individual values between groups by the Wilcoxon rank sum test: 
a vs. b, P  =  0.05;  c vs. d, P  =  0.05 
cvs. e,  P  =  0.05;  fvs. g,  P>0.1 
f vs. h,  P  <  0.01; 
:~ The No. of PFC-As was given as <2/3  X 106 cells when the total number of plaques/ 
3 X 106 cells did not exceed background by more than 2. 
the preinjected antigen was given for the first time, and if the animal was re- 
sponsive to it. 
Thus we have encountered an apparent paradox in that a  nonspecific effect 
(i.e. promotion) appeared to depend on the high degree of specificity involved in 
antigenic recognition. We  shall  consider two  alternative mechanisms which 
may explain this paradox:  expansion of a  cell population, and the release of 
pharmacologically active substances. 
The first mechanism to be considered is the expansion of a  cell population 
other than the cell population which is directly involved  in antibody production. 
We shall illustrate this generality with a  concrete example. The immune re- 
sponse to most antigens appears  to involve interaction between at least two 
functionally different cells (bone marrow-derived cell [B  cell]  and thyallus-de- 
rived cell IT cell]) (28, 29); it is established that the antibody is finally synthe- 
sized by the B cell (6), The T  cell appears to function as helper cell, to interact 
with carrier determinants, and to present (directly or indirectly) the hapten to 
B  cells (11). Interaction of antigen with both cells occurs through cell receptors 
which, up to now, appear to be identical with humoral antibody (compare 30-33 706  ANTIGENIC  PROMOTION 
with 34-36). The question arises whether the range of effective cross-reactivity, 
as defined operationally  from the study of circulating humoral antibody, is iden- 
tical with the effective range of cross-reactivity of the thymus receptors (37). 
These cell-bound receptors might be able to  bind effectively in terms of  the 
helper functions at associatien constants far too low to be detected as cross- 
reactivity in antibody-antigen reactions. Thus the effective range of cross-re- 
TABLE VII 
The Effect of Tolerance on Antigenic Promotion 
Group 
Injections 
i  In adult life  i 
At birth  ] 
Second  I  First 
Alum-precipitated 
HGG 
HGG  Alum-precipitated 
HGG 
Dissociated 
KLH-As 
Dissociated 
KLH-As 
Fraction of 
responding 
rabbits* 
13/15 
7/13 
log10 (PFC-As/node) ~ 
Mean  sD  Range 
2.7  1.2  0-4.2 
1.6  1.5  0-3.4 
Newborn  rabbits were left uninjected  or were given three  injections with HGG intra- 
peritoneally, each of 5 mg in 1 ml of 0.15 ~  NaC1. The first injection was given within 12 
hr of birth and the others 24 and 48 hr later. When the rabbits were 31-50 days old, each 
rabbit of groups I and II received an injection with 2.5 nag of alum-precipitated HGG into 
the footpad. 4 days later, all rabbits were given an injection with dissociated KLH-As (0.5 
mg in 0.2 ~  borate buffer, pH 8.8) into the preinjected footpad. PFC-As assays with cells 
from the draining  popliteal lymph node were carried out 5 days after the last injection. 
* Rabbits whose lymph node cells gave more than two plaques/3  )<  106 cells above the 
background were considered as responders. 
Comparison of individual values between groups by the Wilcoxon rank sum test showed 
that group a was different from group b (0.01 <  P  <  0.02). The response of animals in group 
a  (this table)  is different from the response of animals which are  not rendered tolerant to 
HGG, which are not preinjected in adult life with HGG, but which are preinjected with alum 
precipitate  (group i, Table II; Y =  0.02). The response of animals of group b (this table) is 
similar to the response of animals of group i, Table II (P >  0.2). 
activity of the helper cell's receptors may be such that many unrelated proteins 
might cross-react at the level of the helper cell's receptors. Were this the case, 
division of helper cells in response to an antigen might well increase the number 
of helper ceils (38) which would be available for the interaction between a sub- 
sequently injected hapten-conjugated protein and the B  cell. Cross-reactivity 
of  the  hdper  function, beyond that  observed with  circulating antibody (i.e. 
beyond "classical" cross-reactivity), is the crucial feature of this working hypoth- 
esis.  The  detailed nature of  the  helper function is not important to our argu- 
ment, which is as compatible with receptors on the thymus cell as it is with 
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There are two observations which may, at first,  appear  to be inconsistent 
with this view: (a) that there is correlation between the carrier effect of a pro- 
tein and its effect as a promoter, and (b) that proteins in different states of ag- 
gregation differ in their promotion effect. 
The above inconsistencies may be more apparent than real. The first of the 
above two phenomena may be attributable to the number of potential deter- 
minants  which  can react with  a  helper cell;  the  greater  their diversity, the 
greater  the  probability of interaction with  helper  cells,  and  the  greater  the 
variety of the type of cell receptor which can cross-react with another antigen. 
Thus, carrier effect and promotion effect would be expected to be correlated. 
The different effectiveness in promotion by the same protein molecule in dif- 
ferent states of aggregation is not attributable to the number of determinants, 
but may be attributable to the antigen's ability to reach the T cell receptor and 
to interact with it. This would affect promotion and carrier function to the sam e 
extent, if both depended on cell receptors. 
Though the mediation of promotion through  a cross-reaction at the level of 
the helper cell appears possible and even probable, a second possibility must be 
considered. Is it conceivable that a pharmacologically active substance was re- 
leased, after specific interaction between the antigen and the receptors on the 
thymus-derived cells,  which in  some way facilitates the immune  response  to 
other antigens (41)? From the study of cell-mediated immunity, it is known that 
antigen-stimulated lymphocytes can release substances that have  a variety of 
biological activities (42). Some of these activities may affect humoral as well as 
cellular immunity. It has been reported that specific stimulation  of guinea pigs, 
presensitized to the purified  protein  derivative of tubercle bacilli  (PPD),  re- 
sults in increased antibody response to diphtheria toxoid (43)  as well as in  in- 
creased delayed-type hypersensitivity to bovine gamma globulin (44). 
Promotion which has been reported in this paper may be a common occur- 
rence (45-48), even though it may appear as a rare phenomenon in terms of the 
burgeoning literature on antigenic competition. Indeed, it may be that anti- 
genic promotion is the first event after exposure to two antigens and that anti- 
genic competition is a subsequent, and sometimes, masking event. This idea is 
supported by Waterston's experiment (49); he observed that injection of pig 
erythrocytes into mice reduced the subsequent response to sheep erythrocytes. 
On  the other hand,  spleen cells from pig erythrocyte-immunized mice, when 
cultured in the presence of sheep erythrocytes, gave a higher response to the sheep 
erythrocytes than did the normal spleen cells. Cells responsible for the increase 
in the response to sheep erythrocytes were in the nonadherent cell fraction which 
contained B cells and T cells. Waterston suggested that injection of pig erythro- 
cytes resulted in both the production of an inhibitory factor and an increase in 
cells involved in the response to sheep erythrocytes. The former contributed to 
a decrease in response while the latter contributed to an increase in response to 708  ANTIGENIC  PROMOTION 
a subsequent injection of sheep erythrocytes. The increase in the activity of cells 
involved in the response to sheep erythrocytes, observed by Waterston, could 
be due to either of the two mechanisms  discussed above: proliferation of cells 
due to cross-reactivity at the receptor level or proliferation of cells due to the 
action of a pharmacolGgically active substance.  However, in Waterston's ex- 
periment a slight cross-reactivity between pig erythrocytes and sheep erythro- 
cytes was demonstrated, indicating that  there might be common or cross-re- 
acting determinants, in a classical sense, between these two kinds of erythro- 
cytes. It is,  therefore, questionable whether the conclusions, based on this ex- 
periment, are applicable to other systems of antigen competition or promotion, 
in which classical  cross-reactivity between the two antigens was  not demon- 
strable. 
So far  the mechanism  of antigenic competition remains  unresolved.  It is, 
therefore, futile to speculate whether or not antigenic promotion and antigenic 
competition have  a  common  target. 
Our failure to demonstrate promotion after two injections with a promoting 
antigen might be attributable to a difference between the kinetics of promotion 
after a single preinjection and to the kinetics after two injections with the pro- 
moting antigens. We have explored this possibility by varying the interval be- 
tween the two preinjections (Table VI, groups a-e), and also by varying the 
interval between  the  second preinjection and  the  administration  of HA-As. 
Promotion was not observed in any of these regimeS.  On the other hand, after 
the second preinjection, competition could be demonstrated if an immunizing 
dose (5 rag) of the test antigen was used (Table VI, groups f-h). We, therefore, 
regard it as unlikely that promotion occurs in the whole animal after a secondary 
response to preinjected antigen. If it does take place, it is clearly obscured by a 
much greater effect of simultaneously occurring antigenic competition. Indeed, 
increased antigenic competition has been observed upon secondary injection of 
a competing antigen (45, 46,  50). It is alternatively possible that a  secondary 
injection utilizes all the helper cells so that administration of the "unrelated" 
antigen results in suppression (i.e.  antigen competition) but not in promotion. 
Injection of unrelated macromolecules, before the challenge with an antigen, 
increased the response to  the  hapten  determinant  of  the  antigen.  The  re- 
sponse to  the  protein determinant was  increased in  one case  (Fig.  2,  upper 
panel) but was not increased in another (Fig. 2, lower panel). If the lack of pro- 
motion seen in the latter case was real and was not due to an insufficiently sensi- 
tive test system, it might be considered that  the response to different deter- 
minants of an antigen might be affected to different degrees by preinjection with 
an unrelated macromolecule. Be this as it may, promotion is clearly not limited 
to the chemical hapten, on which most of our work was based, since promotion 
affected protein determinants, at least in one experimental situation. CHIN-YU  WU  AND  BERNHARD  CINADER  709 
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Rabbits were immunized with p-azobenzene arsonic acid derivatives of hu- 
man serum albumin (HA-As) or of dissociated keyhole limpet hemocyanin. The 
IgM response to the hapten was evaluated in terms of the number of hapten- 
specific plaque-forming cells in the lymph node draining the injection site. In 
some experiments, antibody was measured by agglutination of tanned and sen- 
sitized erythrocytes. 
The hapten response of animals immunized with HA-As was increased (pro- 
moting effect) when the animals were injected with one of several structurally 
unrelated macromolecules: keyhole limpet hemocyanin  (KLH), horse spleen 
ferritin  (HSF),  lysozyme  (Lys),  alum-precipitated  human  gamma  globulin 
(alum-precipitated HGG). Different macromolecules differed in the magnitude 
of the promoting effect they induced, e.g., promotion by the associated form of 
KLH was greater than that by the dissociated form; alum-precipitated HGG 
was a better promoter than was soluble HGG. The relative magnitude of pro- 
motion by different macromolecules (associated vs.  dissociated KLH,  alum- 
precipitated vs.  soluble HGG) correlated with the relative magnitude of the 
carrier effect, as judged by the hapten response induced by p-azobenzene arsonic 
acid conjugated to various proteins. Promotion was detected by agglutination 
assay of circulating antibody, by plaque assay of cells from the popliteal lymph 
node draining the site of preinjection, but not by plaque assay of cells from the 
contralateral lymph node. Promotion was dependent on the dose of the promot- 
ing macromolecule and on the dose of the hapten-protein conjugate. It was not 
observed in animals tolerant to the promoting macromolecule. Inhibition  (i.e. 
antigenic competition), rather than promotion, was observed upon a secondary 
response to the preinjected macromolecule or when the hapten-protein conju- 
gate was incorporated in Freund's adjuvant. 
We are indebted to Dr. W. O. Weigle for a gift of keyhole limpet hemocyanin and to Dr. A. 
Kleczkowski for a preparation of tobacco mosaic virus. 
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